COVID-19 pandemic: what about the gonads?

• Published in: Hormones (Athens, Greece) Vol. 20; no. 2; pp. 259 - 268
• Main Authors: Selek, Alev, Güçlü, Metin, Bolu, Şinasi Erol
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01-06-2021
• Subjects: COVID-19 - complications; COVID-19 - epidemiology; Endocrinology; Female; Global Health; Gonadal Disorders - epidemiology; Gonadal Disorders - etiology; Gonads; Humans; Incidence; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Pandemics; Review; Review Article; SARS-CoV-2; Sex Factors; COVID-19; Angiotensin-converting enzyme 2; Androgen; Gonads; Estrogen; Transmembrane serine protease 2
• ISSN: 1109-3099; 2520-8721; 2520-8721
• DOI: 10.1007/s42000-021-00277-3

The novel SARS-CoV-2 has spread to virtually all countries of the world infecting millions of people, the medical burden of this disease obviously being enormous. The gonads of both sexes are among the organs that may be affected by COVID-19 and/or may affect the severity of the disease. The clinical spectrum of SARS-CoV-2 infection clearly differs between genders. The current evidence indicates that the underlying mechanism of such an interaction could be associated with genetic, hormonal, and immunological differences, as well as with gender differences in such habits as smoking and alcohol use. On the other hand, there are controversies as to how and to what extent the gonads could be affected by COVID-19, possibly impacting upon sex steroids, fertility, and other functions. This review underlines the possible mechanisms that could clarify these questions concerning COVID-19 and the gonads. In addition, reference is made to potential new treatment modalities presently under investigation, these supported by accumulating data published in the recent literature.